PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIVENESS-ANALYSIS STUDIES OF TRASTUZUMAB (HERCEPTIN) IN TREATMENT OF HER2-POSITIVE BREAST CANCER
May 1, 2008, 00:00
10.1016/S1098-3015(10)70199-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)70199-6/fulltext
Title :
PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIVENESS-ANALYSIS STUDIES OF TRASTUZUMAB (HERCEPTIN) IN TREATMENT OF HER2-POSITIVE BREAST CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70199-6&doi=10.1016/S1098-3015(10)70199-6
First page :
Section Title :
Open access? :
No
Section Order :
848